Literature DB >> 17244751

Endogenous tumor necrosis factor alpha mediates enhanced apoptosis of cultured villous trophoblasts from intrauterine growth-restricted placentae.

R T Kilani1, M Mackova, S T Davidge, B Winkler-Lowen, N Demianczuk, L J Guilbert.   

Abstract

Tumor necrosis factor alpha (TNFalpha) has been implicated in the abnormally high levels of trophoblast apoptosis seen in placentae from pregnancies complicated by small births. We examined the hypothesis that at physiological (35-50 mmHg) oxygen tensions, the production of TNFalpha stimulates the apoptosis of placental trophoblasts associated with infants that are intrauterine growth-restricted (IUGR). Highly purified cytotrophoblasts (CT) from IUGR-complicated pregnancies spontaneously underwent a higher rate of apoptosis after 24 h of culture at a normoxic (for villous CT) tension of 38 mmHg than did CT from normal placentae. Real-time PCR analysis of TNFalpha mRNA revealed approximately threefold higher levels in IUGR trophoblasts after culturing at a pO2 of 38 mmHg. A higher level of TNFalpha receptor p55 (which mediates apoptosis) was found in IUGR CT by western blot analysis at pO2 of <10, 38, and 140 mmHg. Neutralizing antibody to TNFalpha significantly inhibited the apoptosis of IUGR trophoblasts cultured at 38 mmHg and addition of TNFalpha significantly elevated apoptosis of normal and IUGR trophoblasts but less in IUGR cells cultured at <10 mmHg. We conclude that at physiological oxygen tensions (38 mmHg), villous CT from IUGR pregnancies, when compared with uncomplicated pregnancies, undergo more TNFalpha-induced apoptosis both because of elevated expression of TNFalpha and TNF receptor p55.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17244751     DOI: 10.1530/REP-06-0080

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  9 in total

1.  Genetic recapitulation of human pre-eclampsia risk during convergent evolution of reduced placental invasiveness in eutherian mammals.

Authors:  Michael G Elliot; Bernard J Crespi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-03-05       Impact factor: 6.237

2.  Fetal Growth Trajectories and Their Association with Maternal, Cord Blood, and 5-year Child Adipokines.

Authors:  H C Bartels; A A Geraghty; E C O'Brien; A Kranidi; J Mehegan; C Yelverton; C M McDonnell; F M McAuliffe
Journal:  J Nutr Metab       Date:  2020-09-23

Review 3.  Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium.

Authors:  S Haider; M Knöfler
Journal:  Placenta       Date:  2008-11-22       Impact factor: 3.481

4.  Intrauterine growth restriction: cytokine profiles of trophoblast antigen-stimulated maternal lymphocytes.

Authors:  Raj Raghupathy; Majedah Al-Azemi; Fawaz Azizieh
Journal:  Clin Dev Immunol       Date:  2011-10-31

5.  Expression of CD82 in human trophoblast and its role in trophoblast invasion.

Authors:  Qian Zhang; Dongmei Tan; Wenping Luo; Junjie Lu; Yi Tan
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

6.  Maternal protein restriction induces alterations in hepatic tumor necrosis factor-α/CYP7A1 signaling and disorders regulation of cholesterol metabolism in the adult rat offspring.

Authors:  Xiaomei Liu; Ying Qi; Baoling Tian; Dong Chen; Hong Gao; Chunyan Xi; Yanlin Xing; Zhengwei Yuan
Journal:  J Clin Biochem Nutr       Date:  2014-05-13       Impact factor: 3.114

7.  Tumor necrosis factor-α and pregnancy complications: a prospective study.

Authors:  Fawaz Y Azizieh; Raj G Raghupathy
Journal:  Med Princ Pract       Date:  2014-12-05       Impact factor: 1.927

8.  Taurine transport in human placental trophoblast is important for regulation of cell differentiation and survival.

Authors:  M Desforges; L Parsons; M Westwood; C P Sibley; S L Greenwood
Journal:  Cell Death Dis       Date:  2013-03-21       Impact factor: 8.469

9.  Silencing BRIT1 Facilitates the Abilities of Invasiveness and Migration in Trophoblast Cells.

Authors:  Luping Liu; Li Sun; Jing Zheng; Yanchun Wang
Journal:  Med Sci Monit       Date:  2018-10-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.